I don't check the quotes on too many biotechs, but
I see something like a 50 or 60% gain over the past
month for ANDS owners: I bought 7000 shares of
Anadys in early April, but sold it a week later
and missed the move up, darn it.
INFI has made a fairly good move off the low
quote.yahoo.com
CRXX has been trending up very slowly from the lower $3's
to the upper $3s this past month
My rat dogs TGEN and ORXE near all time lows, the former
dropping again after Parker's latest presentation, the latter
seems to be stuck on 34 cents. Sell in May and go away
wouldn't have saved you here--maybe selling last May and
forever going away would have been good. I wish I could
say that I have some hope of these turning around, but
with only a year of cash left and the threat of delisting
increasingly likely, I don't see the point of watching
these too closely anymore. Apparently the blindness PR
was a good time to unload any tgen shares, wish I had
done that. There has been no chance to unload orxe, it
has been relentless, I have big losses there.
I was going to watch Curagen and Curis, but haven't
watched them at all. Looks like the former is doing
well, while Curis has been fading a bit.
Arena near $5, wow--is that going to be the low?
I had intended to follow all the symbols I had put
in my contest picks, JAZZ for instance was in there,
but I haven't been and I wouldn't confess to owning
anything from my list. As I said before, I will follow
CRXX, just because it is interesting.
Message 24178745 |
